Sabine Bahn.jpg

Prof. Sabine Bahn

Professor Sabine Bahn is a practising psychiatrist, Chair in Neurotechnology and Director of the Cambridge Centre for Neuropsychiatric Research at Cambridge University. Her main research interests are to understand the molecular basis of neuropsychiatric disorders and develop novel diagnostics and therapeutics for psychiatric disorders, with a focus on schizophrenia and mood disorders.

Professor Bahn has published over 180 articles in high impact journals and has co-founded 2 spin-out companies. In 2005, she co-founded Psynova Neurotech Ltd, an award winning company, which has launched the first blood test aiding in the early diagnosis of schizophrenia. In 2011 Psynova Neurotech was acquired by Myriad Genetics, a NASDAQ listed diagnostics company. In 2015 she co-founded a new company, PsyOmics Ltd. PsyOmics aims to develop combined digital and blood based biomarker diagnostics to facilitate earlier and improved diagnosis of key mental health disorders, especially bipolar disorder and depression. PsyOmics has recently been able to secure a second round of investment through the University of Cambridge Seed Fund, Venture Capital and private investors. In 2015 Sabine was elected as Fellow of the Royal Society of Biology. She is a fellow of Lucy Cavendish College.